The risk of bleeding of triple therapy with vitamin K-antagonists, aspirin and clopidogrel after coronary stent implantation: Facts and questions

BACKGROUND: Triple therapy (TT) with vitamin K-antagonists (VKA), aspirin and clopidogrel is the recommended antithrombotic treatment following percutaneous coronary intervention with stent implantation (PCI-S) in patients with an indication for oral anticoagulation. TT is associated with an increas...

Descripción completa

Detalles Bibliográficos
Autor principal: Rubboli, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2011
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390087/
https://www.ncbi.nlm.nih.gov/pubmed/22783307
http://dx.doi.org/10.3724/SP.J.1263.2011.00207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390087/
https://www.ncbi.nlm.nih.gov/pubmed/22783307
http://dx.doi.org/10.3724/SP.J.1263.2011.00207

Ejemplares similares